Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating loss
Research and development	$ 24,344	$ 4,417
Acquired in-process research and development	0	47,716
General and administrative	17,210	18,826
Gain on sale of Aquinox Canada	(7,826)	0
Total operating loss	33,728	70,959
Other income, net	451	1,517
Net loss	$ (33,277)	$ (69,442)
Net loss per common stock - basic and diluted (in dollars per share)	$ (0.64)	$ (2.57)
Basic and diluted weighted average number of common stock outstanding (in shares)	51,825,022	27,030,355